Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Camila Xu + 592 word(s) 592 2020-12-15 07:30:05

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, C. Lymphangioleiomyomatosis. Encyclopedia. Available online: https://encyclopedia.pub/entry/4562 (accessed on 26 September 2026).
Xu C. Lymphangioleiomyomatosis. Encyclopedia. Available at: https://encyclopedia.pub/entry/4562. Accessed September 26, 2026.
Xu, Camila. "Lymphangioleiomyomatosis" Encyclopedia, https://encyclopedia.pub/entry/4562 (accessed September 26, 2026).
Xu, C. (2020, December 24). Lymphangioleiomyomatosis. In Encyclopedia. https://encyclopedia.pub/entry/4562
Xu, Camila. "Lymphangioleiomyomatosis." Encyclopedia. Web. 24 December, 2020.
Lymphangioleiomyomatosis
Edit

Lymphangioleiomyomatosis (LAM) is a condition that affects the lungs, the kidneys, and the lymphatic system. The lymphatic system consists of a network of vessels that transport lymph fluid and immune cells throughout the body.

genetic conditions

References

  1. Harari S, Torre O, Cassandro R, Moss J. The changing face of a rare disease:lymphangioleiomyomatosis. Eur Respir J. 2015 Nov;46(5):1471-85. doi:10.1183/13993003.00412-2015.
  2. Harari S, Torre O, Moss J. Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev. 2011 Mar;20(119):34-44. doi:10.1183/09059180.00011010. Review.
  3. Henske EP, McCormack FX. Lymphangioleiomyomatosis - a wolf in sheep'sclothing. J Clin Invest. 2012 Nov;122(11):3807-16. doi: 10.1172/JCI58709.
  4. Johnson SR, Taveira-DaSilva AM, Moss J. Lymphangioleiomyomatosis. Clin ChestMed. 2016 Sep;37(3):389-403. doi: 10.1016/j.ccm.2016.04.002. Review.
  5. Martignoni G, Pea M, Reghellin D, Gobbo S, Zamboni G, Chilosi M, Bonetti F.Molecular pathology of lymphangioleiomyomatosis and other perivascularepithelioid cell tumors. Arch Pathol Lab Med. 2010 Jan;134(1):33-40. doi:10.1043/2008-0542-RAR1.1.
  6. Meraj R, Wikenheiser-Brokamp KA, Young LR, McCormack FX.Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment.Semin Respir Crit Care Med. 2012 Oct;33(5):486-97.
  7. Moir LM. Lymphangioleiomyomatosis: Current understanding and potentialtreatments. Pharmacol Ther. 2016 Feb;158:114-24. doi:10.1016/j.pharmthera.2015.12.008.
  8. Radzikowska E. Lymphangioleiomyomatosis: New Treatment Perspectives. Lung.2015 Aug;193(4):467-75. doi: 10.1007/s00408-015-9742-6.
  9. Taveira-DaSilva AM, Pacheco-Rodriguez G, Moss J. The natural history oflymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.Lymphat Res Biol. 2010 Mar;8(1):9-19. doi: 10.1089/lrb.2009.0024.
More
Upload a video for this entry
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Camila Xu
View Times: 946
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service